A
Athira Pharma D
D
ATHA
0.23900
USD
-0.02
(-8.08%)
Post Trading
حجم التداول
400
الربح لكل سهم
0
العائد الربحي
-
P/E
-0
حجم السوق
9,331,144
العنوان: Athira Pharma
القطاع: Healthcare
الصناعة: Biotechnology
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.